Cargando…

In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2

Coronavirus desease 2019 (COVID-19) is responsible for more than 1.80 M deaths worldwide. A Quantitative Structure-Activity Relationships (QSAR) model is developed based on experimental pIC(50) values reported for a structurally diverse dataset. A robust model with only five descriptors is found, wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuesta, Sebastián A., Mora, José R., Márquez, Edgar A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923184/ https://www.ncbi.nlm.nih.gov/pubmed/33669720 http://dx.doi.org/10.3390/molecules26041100

Ejemplares similares

DrugBank 5.0: a major update to the DrugBank database for 2018
por: Wishart, David S, et al.
Publicado: (2018)

Databases, DrugBank, and virtual screening platforms for therapeutic development
por: Middha, Sushil Kumar, et al.
Publicado: (2022)

DrugBank: a comprehensive resource for in silico drug discovery and exploration
por: Wishart, David S., et al.
Publicado: (2006)

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors
por: Montanari, Floriane, et al.
Publicado: (2016)

DrugBank: a knowledgebase for drugs, drug actions and drug targets
por: Wishart, David S., et al.
Publicado: (2008)

Evaluating drug-drug interaction information in NDF-RT and DrugBank
por: Peters, Lee B, et al.
Publicado: (2015)

DrugBank 4.0: shedding new light on drug metabolism
por: Law, Vivian, et al.
Publicado: (2014)

DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs
por: Knox, Craig, et al.
Publicado: (2011)

Web-based 3D-visualization of the DrugBank chemical space
por: Awale, Mahendra, et al.
Publicado: (2016)

Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database
por: Southan, Christopher, et al.
Publicado: (2013)

Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking
por: Van Den Driessche, George, et al.
Publicado: (2018)

Non-interacting, Non-opioid, and Non-barbiturate Containing Acute Medication Combinations in Headache: A Pilot Combinatorics Approach Based on DrugBank Database
por: Kaytser, Victor, et al.
Publicado: (2021)

Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach
por: Murugan, Natarajan Arul, et al.
Publicado: (2020)

In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2
por: Alturki, Norah A., et al.
Publicado: (2022)

Search for Novel Lead Inhibitors of Yeast Cytochrome bc1, from Drugbank and COCONUT
por: Jović, Ozren, et al.
Publicado: (2021)

In Silico Searching for Alternative Lead Compounds to Treat Type 2 Diabetes through a QSAR and Molecular Dynamics Study
por: Cabrera, Nicolás, et al.
Publicado: (2022)

PeruNPDB: the Peruvian Natural Products Database for in silico drug screening
por: Barazorda-Ccahuana, Haruna L., et al.
Publicado: (2023)

TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
por: Chen, Calvin Yu-Chian
Publicado: (2011)

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro
por: Hassam, Muhammad, et al.
Publicado: (2022)

SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets
por: Alsulami, Ali F, et al.
Publicado: (2021)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach
por: Singh, Sanjay Kumar, et al.
Publicado: (2021)

GCDB: a glaucomatous chemogenomics database for in silico drug discovery
por: Wei, Yu, et al.
Publicado: (2018)

Network-based in silico drug efficacy screening
por: Guney, Emre, et al.
Publicado: (2016)

In silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens
por: César-Razquin, Adrián, et al.
Publicado: (2018)

ChemBank: a small-molecule screening and cheminformatics resource database
por: Seiler, Kathleen Petri, et al.
Publicado: (2008)

SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery
por: Novick, Paul A., et al.
Publicado: (2013)

Predicting Potential SARS-COV-2 Drugs—In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking
por: Karki, Nischal, et al.
Publicado: (2021)

In-Silico Screening of Lipid-Based Drug Delivery Systems
por: Brinkmann, Joscha, et al.
Publicado: (2020)

In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
por: Chan, Wallace K. B., et al.
Publicado: (2022)

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
por: Abdelkader, Ahmed, et al.
Publicado: (2022)

High performance in silico virtual drug screening on many-core processors
por: McIntosh-Smith, Simon, et al.
Publicado: (2015)

Screening and personalizing nootropic drugs and cognitive modulator regimens in silico
por: Jellen, Leslie C., et al.
Publicado: (2015)

In silico virtual screening approaches for anti-viral drug discovery
por: Murgueitio, Manuela S., et al.
Publicado: (2012)

Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing
por: Ibrahim, Kareem A., et al.
Publicado: (2020)

In silico prediction of mozenavir as a potential drug for SARS-CoV-2 infection via binding multiple drug targets
por: Mamidala, Estari, et al.
Publicado: (2022)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

An ayurvedic perspective along with in silico study of the drugs for the management of SARS-CoV-2
por: Gandhi, Abhay Jayprakash, et al.
Publicado: (2022)

Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease
por: El-Ashrey, Mohamed K., et al.
Publicado: (2022)

Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database
por: Noguchi, Yoshihiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uequc7k8q03jnupfsublbcri6h